Table of Contents
ISRN Inflammation
Volume 2014, Article ID 563628, 7 pages
http://dx.doi.org/10.1155/2014/563628
Research Article

Crotalus durissus collilineatus Venom Induces TNF-α and IL-10 Production in Human Peripheral Blood Mononuclear Cells

1Departamento de Biomedicina e Farmácia, Pontifícia Universidade Católica de Goiás, 74605-140 Goiania, GO, Brazil
2Centro de Estudos e Pesquisas Biológicas (CEPB), Pontifícia Universidade Católica de Goiás, 74605-010 Goiania, GO, Brazil
3Laboratório de Imunogenética, Instituto Butantan, 05503-900 São Paulo, SP, Brazil
4Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, 74605-050 Goiania, GO, Brazil

Received 9 October 2013; Accepted 2 December 2013; Published 19 January 2014

Academic Editors: A. El-Shazly, U. Musabak, T. Oshima, and T. Pessi

Copyright © 2014 Camila Bastos Ribeiro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Uetz and J. Hallerman, “The TIGR Reptile Database,” 2009, http://www.reptile-database.org.
  2. Sociedade Brasileira de Herpetologia—SBH, “Lista Brasileira de Anfíbios e Répteis. Disponível em,” 2011, http://www.sbherpetologia.org.br/.
  3. G. Rosenfeld, “Acidentes por animais peçonhentos,” in Doenças Infecciosas e Parasitárias, R. Veronesi, Ed., pp. 951–962, Rio de Janeiro, Guanabara Koogan, 8th edition, 1991. View at Google Scholar
  4. I. M. B. Francischetti, M. E. C. Gombarovits, J. G. Valenzuela, C. R. Carlini, and J. A. Guimarães, “Intraspecific variation in the venoms of the South American rattlesnake (Crotalus durissus terrificus),” Comparative Biochemistry and Physiology C, vol. 127, no. 1, pp. 23–36, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. J. L. C. Cardoso, F. O. S. França, F. Wen, S. Málaque, and H. V. Junior, Animais Peçonhentos no Brasil, Biologia, Clínica e Terapêutica dos Acidentes, Sarvier, São Paulo, Brazil, 2th edition, 2009.
  6. A. H. Cruz, R. Z. Mendonça, and V. L. Petricevich, “Crotalus durissus terrificus venom interferes with morphological, functional, and biochemical changes in murine macrophage,” Mediators of Inflammation, vol. 2005, no. 6, pp. 349–359, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. D. A. Warrell, “Snake bite,” The Lancet, vol. 375, no. 9708, pp. 77–88, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Oshima-Franco, S. Hyslop, J. Prado-Franceschi, and M. A. Cruz-Höfling, “Neutralizing capacity of antisera raised in horses and rabbits against Crotalus durissus terrificus (South American rattlesnake) venom and its main toxin, crotoxin,” Toxicon, vol. 37, no. 10, pp. 1341–1357, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Rangel-Santos, E. C. Dos-Santos, M. Lopes-Ferreira, C. Lima, D. F. Cardoso, and I. Mota, “A comparative study of biological activities of crotoxin and CB fraction of venoms from Crotalus durissus terrificus, Crotalus durissus cascavella and Crotalus durissus collilineatus,” Toxicon, vol. 43, no. 7, pp. 801–810, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Stocker, “Use of snake venom proteins in medicine,” Schweizerische Medizinische Wochenschrift, vol. 129, no. 6, pp. 205–216, 1999. View at Google Scholar · View at Scopus
  11. D. C. Koh, A. Armugam, and K. Jeyaseelan, “Snake venom components and their applications in biomedicine,” Cellular and Molecular Life Sciences, vol. 63, no. 24, pp. 3030–3041, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Rajendra, A. Armugam, and K. Jeyaseelan, “Neuroprotection and peptide toxins,” Brain Research Reviews, vol. 45, no. 2, pp. 125–141, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. I. F. Purchase, P. A. Botham, L. H. Bruner, O. P. Flint, J. M. Frazier, and W. S. Stokes, “Workshop overview: scientific and regulatory challenges for the reduction, refinement, and replacement of animals in toxicity testing,” Toxicological Sciences, vol. 43, no. 2, pp. 86–101, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Hernández Cruz, S. Garcia-Jimenez, R. Zucatelli Mendonça, and V. L. Petricevich, “Pro- and anti-inflammatory cytokines release in mice injected with Crotalus durissus terrificus venom,” Mediators of Inflammation, vol. 2008, Article ID 874962, 10 pages, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. D. F. Cardoso, M. Lopes-Ferreira, E. L. Faquim-Mauro, M. S. Macedo, and S. H. P. Farsky, “Role of crotoxin, a phospholipase A2 isolated from Crotalus durissus terrificus snake venom, on inflammatory and immune reactions,” Mediators of Inflammation, vol. 10, no. 3, pp. 125–133, 2001. View at Google Scholar · View at Scopus
  16. B. C. Favoretto, R. Ricardi, S. R. Silva et al., “Immunomodulatory effects of crotoxin isolated from Crotalus durissus terrificus venom in mice immunised with human serum albumin,” Toxicon, vol. 57, no. 4, pp. 600–607, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Rangel-Santos, C. Lima, M. Lopes-Ferreira, and D. F. Cardoso, “Immunosuppresive role of principal toxin (crotoxin) of Crotalus durissus terrificus venom,” Toxicon, vol. 44, no. 6, pp. 609–616, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Aderka, “The potential biological and clinical significance of the soluble tumor necrosis factor receptors,” Cytokine and Growth Factor Reviews, vol. 7, no. 3, pp. 231–240, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Thompson-Snipes, V. Dhar, M. W. Bond, T. R. Mosmann, K. W. Moore, and D. M. Rennick, “Interleukin 10: a novel stimulatory factor for mast cells and their progenitors,” Journal of Experimental Medicine, vol. 173, no. 2, pp. 507–510, 1991. View at Google Scholar · View at Scopus
  20. S. F. Ziegler, F. Ramsdell, and M. R. Alderson, “The activation antigen CD69,” Stem Cells, vol. 12, no. 5, pp. 456–465, 1994. View at Google Scholar · View at Scopus
  21. E. H. Neto, A. L. J. Coelho, A. L. F. Sampaio et al., “Activation of human T lymphocytes via integrin signaling induced by RGD-disintegrins,” Biochimica et Biophysica Acta, vol. 1773, no. 2, pp. 176–184, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. H. Sharpe, E. J. Wherry, R. Ahmed, and G. J. Freeman, “The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection,” Nature Immunology, vol. 8, no. 3, pp. 239–245, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. E. A. Said, F. P. Dupuy, L. Trautmann et al., “Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection,” Nature Medicine, vol. 16, no. 4, pp. 452–459, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. K. W. Moore, A. O’Garra, R. Dewaalmalefyt, P. Vieira, and T. R. Mosmann, “Interleukin-10,” Annual Review of Immunology, vol. 11, pp. 165–190, 1993. View at Google Scholar
  25. K. Asadullah, W. Sterry, and H. D. Volk, “Interleukin-10 therapy—review of a new approach,” Pharmacological Reviews, vol. 55, no. 2, pp. 241–269, 2003. View at Publisher · View at Google Scholar · View at Scopus